The Blog
-
Sep 23, 2024Ceritinib (LDK378): A Breakthrough in ALK-Positive Lung Cancer Treatment
READ MORE -
Aug 26, 2024Neratinib: A Crucial Component of Targeted Treatment for CNS Metastases and HER2-Positive Breast Cancer
READ MORE -
Jun 13, 2024Revolutionizing Breast Cancer Treatment with PARP Inhibitors
READ MORE -
Jun 07, 2024Exploring the Role of Toll-like Receptor (TLR) Agonists in Cancer Therapy
READ MORE -
May 27, 2024Advancements in Breast Cancer Treatment: Exploring FDA-Approved Drugs, Nanotechnology, and Future Directions
READ MORE -
May 23, 2024Revolutionizing Breast Cancer Treatment: The Emergence of New Estrogen Receptor Therapies
READ MORE -
May 13, 2024Folate Receptor: A New Horizon in Cancer Therapeutics
READ MORE -
Apr 30, 2024Advances in FGFR: Cancer targets, therapy, and signaling elucidation
READ MORE -
May 05, 2023Discovery and Summary of New Targets for Cancer Immunity
READ MORE